Core Viewpoint - The endoscopic diagnostic and therapeutic device industry is experiencing significant growth driven by increasing demand for minimally invasive procedures, advancements in material technology, and a shift towards single-use consumables to enhance safety and efficiency [4][10][19]. Industry Current Status - The usage rate of single-use consumables in endoscopic devices is continuously increasing, becoming a major trend in the industry. These products, such as biopsy forceps and hemostatic clips, effectively reduce the risk of cross-infection and simplify hospital disinfection processes [4][5]. - Material technology for endoscopic devices has seen significant advancements, with the use of medical-grade polymers, silicone, nickel-titanium alloys, and low-friction coatings enhancing performance and safety [4][10]. - High-end consumables still rely on imports or technical collaborations, as domestic companies face challenges in R&D capabilities and precision manufacturing, leading to a market dominated by a few international brands [4][7]. Customer Demand Differentiation - There is a clear stratification in customer demand for endoscopic consumables. Large hospitals and endoscopy centers prioritize high-quality, high-performance products, while smaller hospitals and clinics focus on cost-effectiveness and ease of use [5][6]. Market Competition Landscape - The endoscopic device market features a coexistence of international brands and domestic companies. International firms lead in high-end consumables, while domestic companies compete aggressively in the mid-to-low-end market, leveraging cost advantages and localized services [7][10]. Development Trends - The growth of the endoscopic diagnostic market in China is primarily driven by the increasing population aged over 40 and rising rates of endoscopic examinations. The population aged 40 and above has grown by 6.64% from 2010 to 2019, reaching nearly 700 million [8][15]. - The trend towards micro-invasive procedures is expanding, with increasing awareness of early screening and treatment for gastrointestinal diseases. This shift is supported by advancements in endoscopic technology and materials [9][10]. - The demand for single-use devices is accelerating due to heightened infection control measures post-COVID-19, with single-use endoscopes and consumables becoming standard in various medical settings [19][20]. Market Opportunities and Drivers - The aging population and changing disease patterns are driving demand for endoscopic devices, particularly for early diagnosis and intervention in gastrointestinal cancers and related conditions [18][19]. - Policies promoting early screening for cancers and major gastrointestinal diseases are increasing the usage of endoscopic devices, contributing to long-term growth in the industry [19][20]. - Technological innovations, including AI-assisted diagnostics and new energy platforms, are enhancing the capabilities of endoscopic devices, leading to the development of new procedures and products [21][22]. Emerging Market Infrastructure - Emerging markets in Southeast Asia, Latin America, the Middle East, and Africa are rapidly upgrading their medical infrastructure, creating opportunities for domestic endoscopic device manufacturers to penetrate these markets due to their cost advantages [22].

Core Insights - Company reported a revenue of 1.565 billion yuan for the first half of 2025, a year-on-year increase of 17.36%, and a net profit of 363 million yuan, up 17.04% from the previous year [1] - The proportion of overseas revenue has increased to 58% of total income, indicating a strong global market presence [1] Group 1: Market Growth and Trends - The endoscopic market is experiencing rapid growth due to advancements in endoscopic surgery and related technologies, leading to increased demand for endoscopic instruments and consumables [1] - The global digestive endoscopy market was valued at $9.2 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching $13.1 billion by 2028 [1] - The global endoscopic diagnostic and therapeutic device market is projected to reach $7 billion by 2025, with an overall growth rate of 6% [1] Group 2: Company Innovations and R&D - Company has a deep understanding of the development trends in minimally invasive technology and clinical needs, having developed nearly 30 core technologies across six major areas of endoscopic diagnosis and treatment [2] - R&D investment for the first half of 2025 was 88.28 million yuan, accounting for 5.64% of revenue, focusing on innovation-driven growth [2] - New innovative products, including the three-arm clamp, have received market approval, and several projects are in the registration submission phase [2] Group 3: Global Expansion and Sustainability - Company has emphasized global expansion, with overseas revenue and profits showing significant growth, up 45% year-on-year [3] - The acquisition of 51% of Spanish company Creo Medical S.L.U. in February marks a significant step in expanding into the European market, with integration progressing smoothly [3] - The construction and operational preparation of the manufacturing center in Thailand is on track to commence production by the end of the year, enhancing the global supply chain [3]